ProShare Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,064
| Closed | -$205K | – | 1859 |
|
|
2024
Q1 | $205K | Buy |
+6,064
| New | +$205K | ﹤0.01% | 1655 |
|
|
2022
Q1 | – | Sell |
-8,322
| Closed | -$308K | – | 2208 |
|
|
2021
Q4 | $308K | Sell |
8,322
-7
| -0.1% | -$259 | ﹤0.01% | 1767 |
|
|
2021
Q3 | $398K | Sell |
8,329
-1,879
| -18% | -$89.8K | ﹤0.01% | 1352 |
|
|
2021
Q2 | $345K | Buy |
10,208
+1,256
| +14% | +$42.4K | ﹤0.01% | 1794 |
|
|
2021
Q1 | $370K | Buy |
8,952
+296
| +3% | +$12.2K | ﹤0.01% | 1665 |
|
|
2020
Q4 | $375K | Buy |
+8,656
| New | +$375K | ﹤0.01% | 1455 |
|
|
2016
Q4 | – | Sell |
-2,483
| Closed | -$43K | – | 1743 |
|
|
2016
Q3 | $43K | Sell |
2,483
-448
| -15% | -$7.76K | ﹤0.01% | 1445 |
|
|
2016
Q2 | $92K | Buy |
2,931
+59
| +2% | +$1.85K | ﹤0.01% | 1526 |
|
|
2016
Q1 | $76K | Sell |
2,872
-271
| -9% | -$7.17K | ﹤0.01% | 1534 |
|
|
2015
Q4 | $138K | Buy |
+3,143
| New | +$138K | ﹤0.01% | 1605 |
|